Daxin Pharma

Delhi, India Founded: 2017 • Age: 9 yrs
Produces pharmaceutical tablets, capsules, liquids, and injections for worldwide healthcare markets.

About Daxin Pharma

Daxin Pharma is a Healthcare company based in Delhi (India) founded in 2017. It produces pharmaceutical tablets, capsules, liquids, and injections for worldwide healthcare markets. It operates on a B2B and Manufacturing model. The company has 78 employees. Its Indian entity Daxin Pharmaceuticals Private Limited reported revenue of β‚Ή93.78 Cr. Daxin Pharma offers products and services including Tablets, Capsules, Liquid Formulations, and Cefa Dry Powder Injections. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Medicines and Quality Assurance.

Company details

Daxin Pharma is a WHO-GMP and ISO 9001 2015 certified company that manufactures high-quality tablets, capsules, liquids, and injections at its facility in Baddi, Himachal Pradesh, India. They emphasize cost-effective, innovative solutions while ensuring compliance with global standards. With offices in New Delhi and Patna, the company serves clients by providing affordable medicines and promoting environmentally friendly practices in the pharmaceutical industry.

  • Headquarters Delhi, India
  • Employees 78
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website daxinpharma.in
  • Legal Name Daxin Pharmaceuticals Private Limited
  • Date of Incorporation 06 Feb, 2014
  • Jurisdiction New Delhi, Delhi, India
Key Metrics
  • Annual Revenue
    ₹93.78 Cr

    FY 2025 · +40% YoY

  • Net Profit
    ₹2.43 Cr

    FY 2025 · 3% margin

  • EBITDA
    ₹5.33 Cr

    FY 2025 · 6% margin

  • Employee Count
    78

Products & Services of Daxin Pharma

Daxin Pharma offers a comprehensive portfolio of products and services, including Tablets, Capsules, Liquid Formulations, and Cefa Dry Powder Injections.

Tablets
Pharmaceuticals

Medicinal tablets for various health treatments and conditions

Capsules
Pharmaceuticals

Encapsulated drugs for targeted medical applications

Liquid Formulations
Pharmaceuticals

Liquid medicines for easy administration and dosage

Cefa Dry Powder Injections
Injections

Powder injections for sterile medical interventions

Board of directors of Daxin Pharmaceuticals Private Limited (Daxin Pharma)

Daxin Pharmaceuticals Private Limited is the primary company behind Daxin Pharma. The board of Daxin Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Sheela Jha, appointed in 2014. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Sheela Jha
DIN 06777983
Director06 Feb 201412 yrs 8 moDaxin Pharmaceuticals Private Limited
Nikhil Kumar Jha
DIN 03376717
Director16 Feb 201412 yrs 8 moDaxin Pharmaceuticals Private Limited

Financials of Daxin Pharma

Figures of Daxin Pharmaceuticals Private Limited, the primary company behind Daxin Pharma, for FY 2025. Revenue was ₹93.78 Cr (+40% year on year). Net profit was ₹2.43 Cr (3% margin). EBITDA was ₹5.33 Cr (6% margin). Revenue has grown at a compounded annual rate of +58% over three years and +56% over five years.

  • ₹93.78 CrRevenue · FY 2025 · +40% YoY
  • ₹2.43 CrNet profit · 3% margin
  • ₹5.33 CrEBITDA · 6% margin
  • ₹9.84 CrPaid-up capital
  • 78Employees (provident fund records)
  • +58%Revenue CAGR, 3 years
  • +56%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Daxin Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Daxin Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Daxin Pharma

The website of Daxin Pharma (daxinpharma.in) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▲ 61.2% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Daxin Pharma

Daxin Pharma was founded in 2017.

Daxin Pharma is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Daxin Pharma has 78 employees.

The primary company behind Daxin Pharma, Daxin Pharmaceuticals Private Limited, reported revenue of β‚Ή93.78 Cr for FY 2025, up 40% year on year.

Daxin Pharma is a WHO-GMP and ISO 9001 2015 certified company that manufactures high-quality tablets, capsules, liquids, and injections at its facility in Baddi, Himachal Pradesh, India. They emphasize cost-effective, innovative solutions while ensuring compliance with global standards. With offices in New Delhi and Patna, the company serves clients by providing affordable medicines and promoting environmentally friendly practices in the pharmaceutical industry.

Daxin Pharma offers Tablets, Capsules, Liquid Formulations, and Cefa Dry Powder Injections.

Daxin Pharma operates through Daxin Pharmaceuticals Private Limited.

The legal entities of Daxin Pharma currently have 2 directors, including Sheela Jha, Nikhil Kumar Jha.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available